These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 22951237

  • 1. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME.
    J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
    [Abstract] [Full Text] [Related]

  • 2. MAOIs and depression treatment guidelines.
    Thase ME.
    J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA.
    J Clin Psychiatry; 2012 Jul; 73 Suppl 1():17-24. PubMed ID: 22951238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MAOIs and transdermal delivery.
    Vandenberg CM.
    J Clin Psychiatry; 2012 Sep; 73(9):e28. PubMed ID: 23059160
    [Abstract] [Full Text] [Related]

  • 8. Psychopharmacology column: why choose selegiline transdermal system for refractory depression?
    Tobin M.
    Issues Ment Health Nurs; 2007 Feb; 28(2):223-8. PubMed ID: 17365170
    [No Abstract] [Full Text] [Related]

  • 9. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD, Bodkin JA.
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [Abstract] [Full Text] [Related]

  • 10. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
    Cohen LJ, Sclar DA, Culpepper L, Flockhart DA, Hirschfeld RM, Thase ME, VanDenBerg CM.
    J Clin Psychiatry; 2012 Dec; 73 Suppl 1():42-5. PubMed ID: 22951242
    [No Abstract] [Full Text] [Related]

  • 11. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH.
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [Abstract] [Full Text] [Related]

  • 12. Revisiting monoamine oxidase inhibitors.
    Krishnan KR.
    J Clin Psychiatry; 2007 Mar; 68 Suppl 8():35-41. PubMed ID: 17640156
    [Abstract] [Full Text] [Related]

  • 13. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI, Fischer HD, Herrmann N, Huo CY, Anderson GM, Rochon PA.
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [Abstract] [Full Text] [Related]

  • 14. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    Rapaport MH.
    J Clin Psychiatry; 2007 Dec; 68 Suppl 8():42-6. PubMed ID: 17640157
    [Abstract] [Full Text] [Related]

  • 15. The use of MAOIs in primary care.
    Culpepper L.
    J Clin Psychiatry; 2012 May; 73(5):e19. PubMed ID: 22697202
    [Abstract] [Full Text] [Related]

  • 16. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI, Herrmann N, Walker SE.
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ, Shin M, McInnis MG, Bostwick JR.
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.